In this episode of 20VC, Harry Stebbings interviews Miles Dieffenbach, Managing Director of Investments at Carnegie Mellon's $4 billion Endowment Fund. Miles shares his personal story of overcoming cancer and how it shaped his investment mindset. The conversation covers CMU's portfolio construction, asset allocation strategies, and views on venture capital, including the debate on whether LPs are adequately compensated for the risks involved. Miles discusses the challenges and opportunities in venture investing, the importance of manager selection, and the evolving landscape of multi-stage funds. He also touches on the significance of liquidity, the role of public markets, and the potential impact of AI on the venture capital industry, offering insights into fund management, investment strategies, and the future of venture capital.
Sign in to continue reading, translating and more.
Continue